
Integrating network pharmacology with ex-vivo analysis to assess the effect of IL-2 in halting breast cancer: involvement of Treg/CTLA-4/Blimp-1/caspase-3 | Scientific Reports
<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5FNWV2YkpSUmFKN056aWZkYVl4LVYtT1ZBTlh6TVBBZ29XZVV2dUxlT1RzV2p0TXJpMXNUckNsbDl6ZnZfdHNILXFuNHhfS3NtY0JYcGt6NFVobl9xX0E0?oc=5" target="_blank">Integrating network pharmacology with ex-vivo analysis to assess the effect of IL-2 in halting breast cancer: involvement of Treg/CTLA-4/Blimp-1/caspase-3 | Scientific Reports</a>&nbsp;&nbsp;<font color="#6f6f6f">Nature</font>
